Sun.May 18, 2025

article thumbnail

Alzheimer’s Disease Now Has Its First FDA-Cleared Blood Test

MedCity News

Fujirebio Diagnostics blood test for Alzheimers disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies. The post Alzheimers Disease Now Has Its First FDA-Cleared Blood Test appeared first on MedCity News.

FDA 259
article thumbnail

FDA clears first blood test for Alzheimer's disease

pharmaphorum

The FDA has approved the first blood test for Alzheimer's disease based on a blood test from Fujirebio in a step forward for early diagnosis

FDA 76
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Connected Care, Shared Goals: Designing Whole-Person Care for Complex Patient Populations

MedCity News

As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that reaches individuals with complex care needs, supports whole-person health initiatives and strengthens care across the board.

Patients 249
article thumbnail

FDA finally okays Novavax's COVID-19 jab, with restrictions

pharmaphorum

FDA finally okays Novavax's COVID-19 jab, with restrictions Phil.

FDA 66
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it

MedCity News

As demand for trial sites increases, more investigators are overburdened or experiencing burnout. What can the industry do to help? The post Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it appeared first on MedCity News.

165
165

More Trending

article thumbnail

Malaysia's Pharmaceutical Market in 2025: Embracing Transparency

Contrarian Sales Techniques

As of May 1, 2025, Malaysia has implemented a significant policy change aimed at enhancing transparency in the pharmaceutical sector. Under the Price Control and Anti-Profiteering (Price Labelling for Medicines) Order 2025 , all private healthcare facilities and community pharmacies are mandated to display the prices of all medicines, including prescription drugs, over-the-counter medications, traditional remedies, health supplements, and custom-made preparations.

article thumbnail

Pharmaceutical Marketing Strategies that Truly Connect with HCPs

Pharma Marketing Network

Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.

article thumbnail

PFAS Regulations & Pharmaceutical Packaging: Navigating the Changing Landscape

PharmaTech

Webinar Date/Time: Tue, Jun 10, 2025 9:00 AM EDT

article thumbnail

Must Watch Pharmaceutical Trends

Pharma Marketing Network

Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

NCCN Adds Naxitamab as Category 2A Recommendation for High-Risk Neuroblastoma

Pharmacy Times

Naxitamab-gqgk has been added as a Category 2A recommendation in the updated National Comprehensive Cancer Network (NCCN) guidelines for high-risk neuroblastoma, reflecting growing consensus on its role in treating relapsed or refractory disease.

article thumbnail

Why WeightWatchers Filed for Bankruptcy

MedCity News

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn’t adapt fast enough to a rapidly changing weight-loss environment spurred by the rising popularity of GLP-1s, experts said. The post Why WeightWatchers Filed for Bankruptcy appeared first on MedCity News.

294
294
article thumbnail

Cleveland Clinic Digital Chief: Pick AI Problems That Clinicians Actually Care About

MedCity News

Ensuring buy-in from end users is critical to hospitals AI success. To achieve buy-in, hospitals should start by adopting AI tools that address the problems that physicians and nurses have identified as most important to them, said Rohit Chandra, chief digital officer at Cleveland Clinic. The post Cleveland Clinic Digital Chief: Pick AI Problems That Clinicians Actually Care About appeared first on MedCity News.